- What is Third Rock Ventures' investment focus?
- Third Rock Ventures is a healthcare-focused venture capital firm specializing in the ideation, formation, and early-stage development of life sciences and biotechnology companies, primarily in therapeutics, medical devices, and diagnostics.
- When was Third Rock Ventures founded?
- Third Rock Ventures was founded in 2007.
- Can you describe Third Rock Ventures' investment model?
- Third Rock Ventures employs a venture creation model, actively collaborating with academic and scientific visionaries. They take a hands-on operational role during initial development, with investment team members often serving as founding management, establishing culture, designing R&D strategies, and providing initial capital.
- What is a recent investment made by Third Rock Ventures?
- In December 2025, Third Rock Ventures led a $165 million Series A round for Syremis Therapeutics, a company focused on novel therapies for neuropsychiatric conditions.
- Which investment stages does Third Rock Ventures focus on?
- Third Rock Ventures focuses on Seed and Pre-Seed investment stages.
- Who are the co-founders of Third Rock Ventures?
- The co-founders of Third Rock Ventures include Robert Tepper, Kevin Starr, and Mark Levin.
- What is the most notable portfolio company for Third Rock Ventures?
- One notable portfolio company for Third Rock Ventures is Syremis Therapeutics, which secured a $165 million Series A round in December 2025.
